Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair

Randomized Clinical Trial: Transverse Abdominis Plane Block Versus no Block in Laparoscopic Ventral Hernia Repair

The current study aims to determine if transverse abdominis plane block using local anesthetic agents (bupivacaine 0.25% + Ropivacaine 0.20%) decreases the post operative pain and helps in early mobilization or discharge from hospital in patients undergoing laparoscopic ventral hernia repair.

Patients meeting inclusion criteria would be randomised after admission. Those patients in experimental arm shall receive the TAP block under USG guidance while those in control arm do not receive any block. Surgery shall be proceeded in the usual manner in all the patients and assessment for pain starts in the immediate post operative or recovery room after the patient is completely conscious. The total amount of analgesic required by the patient is measured. Pain assessment is done using the visual analog scale (VAS) at regular intervals until follow up review.

Inclusion Criteria:

• All patients undergoing laparoscopic ventral hernia repair during the study period

Exclusion Criteria:

• Age <15 or greater than 75 years
• ASA > 3
• Obstructed , recurrent or strangulated hernia
• Lap assisted open hernia repair
• Patients undergoing component separation
• Parastomal hernia, spigelian hernia, lumbar hernia
• Patients with Chronic kidney disease, bronchial asthma
• Patients allergic to bupivacaine or NSAIDs
• Not willing to participate